Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FRACTYL HEALTH, INC.GUTS · Entity 6700 | President, Chief Product Off. | December 15, 2025 | December 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FRACTYL HEALTH, INC.
Report date December 15, 2025 · Filed December 17, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.24 · Expires 2035-12-14 | Direct | 845,226 |
Reported balance
After 2025-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-15 · Grant · Acquired 845,226 · Balance 845,226 F1: The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2025 Filed Dec 17, 2025 18:00 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 845,226 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001193125-25-323018 · ownership.xml · derivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 845,226 Underlying: Common Stock · 845,226 shares Expires 2035-12-14 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 20:59 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 104,400 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-25-031262 · ownership.xml · derivative · entry 2 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,400 Underlying: Common Stock · 104,400 shares Expires 2034-01-31 F2 · derivative.exercise_date: In connection with the Issuer's initial public offering, on February 1, 2024 the Reporting Person was granted, subject to the satisfaction of certain performance criteria, an option to purchase 174,000 shares of common stock to vest in the form of shares of the Issuer's common stock in four substantially equal installments on December 31, 2024 and each of the first three anniversaries thereof. On February 27, 2025, the Issuer's administrator determined that the performance criteria were partially met, resulting in 104,400 shares subject to such option being earned, of which 25% vested on December 31, 2024 and the remaining 75% will vest in substantially equal installments on the first three anniversaries thereof. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 20:59 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | GrantStock Option (right to buy) · Derivative | 179,700 | $0.00 Strike: $1.46 | $0.00 |
DisclosureSEC source: 0000950170-25-031262 · ownership.xml · derivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,700 Underlying: Common Stock · 179,700 shares Expires 2035-02-26 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in equal installments on each of the first four anniversaries of the grant date, subject to the Reporting Persons's continuing in employment through each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionStock Option · Derivative | 22,346 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · derivative · entry 8 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,924 Underlying: Common Stock · 22,346 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 22,346 | $1.81 | $40,464.14 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · nonDerivative · entry 4 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,544 F1 · kind: Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.8000 to $1.8800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 22,346 | $1.70 | $37,988.20 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · nonDerivative · entry 3 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionStock Option · Derivative | 21,472 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · derivative · entry 7 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,270 Underlying: Common Stock · 21,472 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 21,472 | $1.95 | $41,801.69 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · nonDerivative · entry 2 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,544 F1 · kind: Represents sales pursuant to a Rule 10b5-1 plan that the Reporting Person entered into on September 13, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.9000 to $2.0400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 30, 2025 Filed Feb 3, 2025 18:03 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 21,472 | $1.70 | $36,502.40 |
DisclosureSEC source: 0000950170-25-012530 · ownership.xml · nonDerivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 175,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 18:25 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 64,197 | $2.47 | $158,540.91 |
DisclosureSEC source: 0000950170-24-126558 · ownership.xml · nonDerivative · entry 2 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,544 F2 · kind: Represents shares sold for tax-withholding purposes due upon the vesting of the restricted stock units. Read SEC document |
| November 10, 2024 Filed Nov 13, 2024 18:25 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionRestricted Stock Unit · Derivative | 187,257 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-126558 · ownership.xml · derivative · entry 5 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 187,257 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. Read SEC document |
| November 10, 2024 Filed Nov 13, 2024 18:25 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 187,257 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-126558 · ownership.xml · nonDerivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested in full on November 10, 2024 and have no expiration date. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:39 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionStock Option · Derivative | 95,484 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0000950170-24-106530 · ownership.xml · derivative · entry 5 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,484 shares Expires 2024-11-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:39 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | SaleCommon Stock | 65,000 | $2.90 | $188,474.00 |
DisclosureSEC source: 0000950170-24-106530 · ownership.xml · nonDerivative · entry 2 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,484 F1 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $2.85 to $3.06. The Reporting Person undertakes to provide upon request the Staff of the Securities and Exchange Commission, the Issuer, or any stockholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:39 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | Exercise / conversionCommon Stock | 95,484 | $1.70 | $162,322.80 |
DisclosureSEC source: 0000950170-24-106530 · ownership.xml · nonDerivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,484 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries C-2 Preferred Stock · Derivative | 32,514 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · derivative · entry 6 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 15,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries C-1 Preferred Stock · Derivative | 44,730 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · derivative · entry 5 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 20,843 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries B Preferred Stock · Derivative | 177,726 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · derivative · entry 4 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 0 Underlying: Common Stock · 82,817 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionSeries A Preferred Stock · Derivative | 50,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · derivative · entry 3 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 23,299 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.exercise_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F1 · derivative.expiration_date: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F2 · derivative.underlying_shares: The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 118,810 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · nonDerivative · entry 2 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Trust Disclosed balance after: 118,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:37 UTC | FRACTYL HEALTH, INC. GUTS · Entity 6700 | ConversionCommon Stock | 23,299 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-012836 · ownership.xml · nonDerivative · entry 1 Caplan Jay David · CIK 0001419217 · President, Chief Product Off. 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 358,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into common stock in accordance with the terms of such preferred stock. F2 · balance_after: The Reporting Person's Form 3 filed on February 1, 2024 inadvertently omitted the securities held by the Jay D. Caplan 2021 Irrevocable Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.